-
1
-
-
10544253846
-
Inherited thrombophilia. Part I
-
Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlback B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia. Part I. Thromb Haemost 1996; 76: 651-62.
-
(1996)
Thromb Haemost
, vol.76
, pp. 651-662
-
-
Lane, D.A.1
Mannucci, P.M.2
Bauer, K.A.3
Bertina, R.M.4
Bochkov, N.P.5
Boulyjenkov, V.6
Chandy, M.7
Dahlback, B.8
Ginter, E.K.9
Miletich, J.P.10
Rosendaal, F.R.11
Seligsohn, U.12
-
2
-
-
0023851665
-
The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insight into its possible mechanism of action
-
Broze GJ Jr, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Blood 1988; 71: 335-43.
-
(1988)
Blood
, vol.71
, pp. 335-343
-
-
Broze Jr., G.J.1
Warren, L.A.2
Novotny, W.F.3
Higuchi, D.A.4
Girard, J.J.5
Miletich, J.P.6
-
3
-
-
0024269093
-
Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: Evidence for a two-step model of inhibition
-
Warn-Cramer BJ, Rao LVM, Maki SL, Rapaport SI. Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: evidence for a two-step model of inhibition. Thromb Haemost 1988; 60: 453-6.
-
(1988)
Thromb Haemost
, vol.60
, pp. 453-456
-
-
Warn-Cramer, B.J.1
Rao, L.V.M.2
Maki, S.L.3
Rapaport, S.I.4
-
5
-
-
0032992392
-
Low levels of heparin-releasable tissue factor pathway inhibitor in young patients with thrombosis
-
Ariëns RAS, Alberio G, Moia M, Mannucci PM. Low levels of heparin-releasable tissue factor pathway inhibitor in young patients with thrombosis. Thromb Haemost 1999; 81: 203-7.
-
(1999)
Thromb Haemost
, vol.81
, pp. 203-207
-
-
Ariëns, R.A.S.1
Alberio, G.2
Moia, M.3
Mannucci, P.M.4
-
6
-
-
0035014293
-
Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis
-
Amini-Nekoo A, Futers TS, Moia M, Mannucci PM, Grant PJ, Ariëns RAS. Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis. Br J Haematol 2001; 113: 537-43.
-
(2001)
Br J Haematol
, vol.113
, pp. 537-543
-
-
Amini-Nekoo, A.1
Futers, T.S.2
Moia, M.3
Mannucci, P.M.4
Grant, P.J.5
Ariëns, R.A.S.6
-
7
-
-
0038481254
-
Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis
-
Dahm A, van Hylckama Vlieg A, Bendz B, Rosendaal F, Bertina RM, Sandset PM. Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis. Blood 2003; 101: 4387-92.
-
(2003)
Blood
, vol.101
, pp. 4387-4392
-
-
Dahm, A.1
Van Hylckama Vlieg, A.2
Bendz, B.3
Rosendaal, F.4
Bertina, R.M.5
Sandset, P.M.6
-
8
-
-
0642372609
-
Poor anticoagulant response to tissue factor pathway inhibitor in patients with venous thrombosis
-
Tardy-Poncet B, Tardy B, Laporte S, Mismetti P, Amiral J, Piot M, Reynaud J, Campos L, Decousus HJ. Poor anticoagulant response to tissue factor pathway inhibitor in patients with venous thrombosis. J Thromb Haemost 2003; 1: 507-10.
-
(2003)
J Thromb Haemost
, vol.1
, pp. 507-510
-
-
Tardy-Poncet, B.1
Tardy, B.2
Laporte, S.3
Mismetti, P.4
Amiral, J.5
Piot, M.6
Reynaud, J.7
Campos, L.8
Decousus, H.J.9
-
9
-
-
0036335480
-
The - 33T > C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations
-
Ameziane N, Seguin C, Borgel D, Fumeron F, Moatti D, Alhenc-Gelas M, Grandchamp B, Aiach M, Emmerich J, de Prost D. The - 33T > C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations. Thromb Haemost 2002; 88: 195-9.
-
(2002)
Thromb Haemost
, vol.88
, pp. 195-199
-
-
Ameziane, N.1
Seguin, C.2
Borgel, D.3
Fumeron, F.4
Moatti, D.5
Alhenc-Gelas, M.6
Grandchamp, B.7
Aiach, M.8
Emmerich, J.9
De Prost, D.10
-
10
-
-
0037035484
-
Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V Leiden
-
Eitzman DT, Westrick RJ, Bi X, Manning SL, Wilkinson JE, Broze GJ, Ginsburg D. Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V Leiden. Circulation 2002; 105: 2139-42.
-
(2002)
Circulation
, vol.105
, pp. 2139-2142
-
-
Eitzman, D.T.1
Westrick, R.J.2
Bi, X.3
Manning, S.L.4
Wilkinson, J.E.5
Broze, G.J.6
Ginsburg, D.7
-
11
-
-
5644248267
-
Potential of free-form TFPI and PAI-1 to be useful markers of early atherosclerosis in a Japanese general population (the Suita Study): Association with the intimal-medial thickness of carotid arteries
-
Sakata T, Mannami T, Baba S, Kokubo Y, Kario K, Okamoto A, Kumeda K, Ohkura N, Katayama Y, Miyata T, Tomoike H, Kato H. Potential of free-form TFPI and PAI-1 to be useful markers of early atherosclerosis in a Japanese general population (the Suita Study): association with the intimal-medial thickness of carotid arteries. Atherosclerosis 2004; 176: 355-60.
-
(2004)
Atherosclerosis
, vol.176
, pp. 355-360
-
-
Sakata, T.1
Mannami, T.2
Baba, S.3
Kokubo, Y.4
Kario, K.5
Okamoto, A.6
Kumeda, K.7
Ohkura, N.8
Katayama, Y.9
Miyata, T.10
Tomoike, H.11
Kato, H.12
-
12
-
-
0346500570
-
Tissue factor, tissue factor pathway inhibitor and cytoadhesive molecules in patients with an acute coronary syndrome
-
Maly M, Vojacek J, Hrabos V, Kvasnicka J, Salaj P, Durdil V. Tissue factor, tissue factor pathway inhibitor and cytoadhesive molecules in patients with an acute coronary syndrome. Physiol Res 2003; 52: 719-29.
-
(2003)
Physiol Res
, vol.52
, pp. 719-729
-
-
Maly, M.1
Vojacek, J.2
Hrabos, V.3
Kvasnicka, J.4
Salaj, P.5
Durdil, V.6
-
13
-
-
10644246973
-
The relationship of TFPI, Lp (a), and oxidized LDL antibody levels in patients with coronary artery disease
-
Bilgen D, Sonmez H, Ekmekci H, Ulutin T, Ozturk Z, Kokoglu E, Bayram C, Soner A, Domanic N. The relationship of TFPI, Lp (a), and oxidized LDL antibody levels in patients with coronary artery disease. Clin Biochem 2005; 38: 92-6.
-
(2005)
Clin Biochem
, vol.38
, pp. 92-96
-
-
Bilgen, D.1
Sonmez, H.2
Ekmekci, H.3
Ulutin, T.4
Ozturk, Z.5
Kokoglu, E.6
Bayram, C.7
Soner, A.8
Domanic, N.9
-
14
-
-
0345599092
-
Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes
-
Golino P, Ravera A, Ragni M, Cirillo P, Piro O, Chiariello M. Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes. Circulation 2003; 108: 2864-9.
-
(2003)
Circulation
, vol.108
, pp. 2864-2869
-
-
Golino, P.1
Ravera, A.2
Ragni, M.3
Cirillo, P.4
Piro, O.5
Chiariello, M.6
|